138 related articles for article (PubMed ID: 15523179)
1. Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis.
García-Tapia A; Rodríguez JC; Ruiz M; Royo G
Chemotherapy; 2004 Nov; 50(5):211-3. PubMed ID: 15523179
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis.
Rodríguez JC; Ruiz M; López M; Royo G
Int J Antimicrob Agents; 2002 Dec; 20(6):464-7. PubMed ID: 12458143
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model.
Cremades R; Rodríguez JC; García-Pachón E; Galiana A; Ruiz-García M; López P; Royo G
J Antimicrob Chemother; 2011 Oct; 66(10):2281-3. PubMed ID: 21733966
[TBL] [Abstract][Full Text] [Related]
4. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
Escribano I; Rodríguez JC; Llorca B; García-Pachon E; Ruiz M; Royo G
Chemotherapy; 2007; 53(6):397-401. PubMed ID: 17934259
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria.
Rodriguez Díaz JC; López M; Ruiz M; Royo G
Int J Antimicrob Agents; 2003 Jun; 21(6):585-8. PubMed ID: 12791475
[TBL] [Abstract][Full Text] [Related]
6. Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis.
Rodríguez JC; Cebrián L; López M; Ruiz M; Jiménez I; Royo G
J Antimicrob Chemother; 2004 Mar; 53(3):441-4. PubMed ID: 14963069
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.
Guna R; Muñoz C; Domínguez V; García-García A; Gálvez J; de Julián-Ortiz JV; Borrás R
J Antimicrob Chemother; 2005 Jun; 55(6):950-3. PubMed ID: 15824090
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
Sulochana S; Rahman F; Paramasivan CN
J Chemother; 2005 Apr; 17(2):169-73. PubMed ID: 15920901
[TBL] [Abstract][Full Text] [Related]
10. Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model.
Cremades R; Rodríguez JC; Garcia-Pachón E; Galiana A; Ruiz-García M; López P; Royo G
APMIS; 2011 Apr; 119(4-5):304-8. PubMed ID: 21492231
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.
Vera-Cabrera L; Castro-Garza J; Rendon A; Ocampo-Candiani J; Welsh O; Choi SH; Blackwood K; Molina-Torres C
Antimicrob Agents Chemother; 2005 Oct; 49(10):4351-3. PubMed ID: 16189119
[TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of Linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria.
Molicotti P; Ortu S; Bua A; Cannas S; Sechi LA; Zanetti S
New Microbiol; 2006 Oct; 29(4):275-80. PubMed ID: 17201094
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
Erturan Z; Uzun M
Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
[TBL] [Abstract][Full Text] [Related]
14. Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis.
Hui M; Au-Yeang C; Wong KT; Chan CY; Yew WW; Leung CC
Int J Antimicrob Agents; 2008 Apr; 31(4):395-6. PubMed ID: 18272351
[No Abstract] [Full Text] [Related]
15. Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis.
Rodriguez Díaz JC; Ruiz M; López M; Royo G
Int J Antimicrob Agents; 2003 Apr; 21(4):354-6. PubMed ID: 12672583
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years.
Huang TS; Liu YC; Sy CL; Chen YS; Tu HZ; Chen BC
Antimicrob Agents Chemother; 2008 Jun; 52(6):2226-7. PubMed ID: 18391030
[TBL] [Abstract][Full Text] [Related]
17. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
18. A whole blood bactericidal assay for tuberculosis.
Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Paramasivan CN; Sulochana S; Kubendiran G; Venkatesan P; Mitchison DA
Antimicrob Agents Chemother; 2005 Feb; 49(2):627-31. PubMed ID: 15673743
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis from Shenyang, north of China.
Liu H; Wang Y; Liu N; Zhao L
Indian J Med Microbiol; 2015 Feb; 33 Suppl():164-5. PubMed ID: 25657144
[No Abstract] [Full Text] [Related]
[Next] [New Search]